Protalix Biotherapeutics, Inc. (PLX)
1.90
-0.01
(-0.52%)
USD |
NYAM |
May 19, 16:00
1.95
+0.05
(+2.63%)
Pre-Market: 08:10
Protalix Biotherapeutics EPS Diluted (Quarterly) : 0.2206 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.023 |
| Lisata Therapeutics, Inc. | -0.4984 |
| Curis, Inc. | -1.250 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -1.045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 18.32M |
| Revenue (Quarterly) | 33.75M |
| Total Expenses (Quarterly) | 15.43M |
| Enterprise Value | 109.77M |
| Gross Profit Margin (Quarterly) | 87.77% |
| Profit Margin (Quarterly) | 54.27% |
| Earnings Yield | 9.65% |
| Operating Earnings Yield | 12.80% |
| Normalized Earnings Yield | 9.647 |